Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CLINGEN Mutations in the Human Argininosuccinate Synthetase (ASS1) Gene, Impact on Patients, Common Changes, and Structural Considerations. 28111830 2017
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 AlteredExpression disease BEFREE Classical citrullinemia (CTLN1) is an inborn error of the urea cycle caused by reduced/abolished activity of argininosuccinate synthetase due to mutations in the ASS1 gene. 25179242 2015
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CLINGEN High prevalence of neonatal presentation in Korean patients with citrullinemia type 1, and their shared mutations. 23246278 2013
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CLINGEN Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene. 19006241 2009
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 GeneticVariation disease BEFREE Mild citrullinemia is an allelic variant of classical citrullinemia type I also caused by deficiency of the urea cycle enzyme argininosuccinate synthetase (ASS). 18473344 2008
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CLINGEN Prenatal diagnosis of citrullinemia and argininosuccinic aciduria: evidence for a transmission ratio distortion in citrullinemia. 16475226 2006
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 GeneticVariation disease BEFREE Classical citrullinemia (CTLN1), a rare autosomal recessive disorder, is caused by mutations of the argininosuccinate synthetase (ASS) gene, localized on chromosome 9q34.1. 12815590 2003
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CLINGEN Correction of argininosuccinate synthetase (AS) deficiency in a murine model of citrullinemia with recombinant adenovirus carrying human AS cDNA. 11083500 2000
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CLINGEN Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia. 10097149 1999
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 GeneticVariation disease BEFREE We have previously identified 20 mutations in ASS mRNA of human classical citrullinemia and already established the DNA diagnosis of seven mutations as follows. 9090528 1997
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 GeneticVariation disease BEFREE Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia. 7557970 1995
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CLINGEN Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene. 8197477 1994
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CLINGEN Analysis of a splice acceptor site mutation which produces multiple splicing abnormalities in the human argininosuccinate synthetase locus. 2246255 1990
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CLINGEN Urea cycle enzymopathies. 6763345 1982
Argininosuccinic Acid Synthetase Deficiency, Complete
0.550 Biomarker disease CTD_human